Stocks
ETFs
Options
Commodities
Crypto
Currency
Pro Newsletters
Research Tools
Calendars
Economic Indicators
Class Actions
Calculators
Education
About Us
Working with TipRanks
Follow Us
Ondine Biomedical, Inc. (GB:OBI)
LSE:OBI
RESEARCH TOOLSreports
Holding GB:OBI?
Track your performance easily
OBI Stock Chart & Stats
Day’s Range0p - 0p
52-Week Range5.00p - 11.40p
Previous Close8.25p
Volume30.61K
Average Volume (3M)440.51K
Market Cap
£22.88M
Enterprise Value21.50M
Total Cash (Recent Filing)C$2.98M
Total Debt (Recent Filing)C$541.00K
Price to Earnings (P/E)―
Beta0.01
Next Earnings
May 15, 2025EPS EstimateN/A
Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)-0.04
Shares Outstanding406,340,334
10 Day Avg. Volume1,699,628
30 Day Avg. Volume440,510
Standard Deviation0.18
R-Squared0.00058
Alpha-0.04
Financial Highlights & Ratios
Price to Book (P/B)0.00
Price to Sales (P/S)36.58
Price to Cash Flow (P/CF)-4.20
P/FCF Ratio0.00
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price Target
55.00pPrice Target Upside566.67% Upside
Rating ConsensusModerate Buy
Number of Analyst Covering1
Ondine Biomedical, Inc. News
PremiumCompany Announcements
Ondine Biomedical Gains Investor Attention Post-IPO
PremiumCompany Announcements
Ondine Biomedical Sees Shift in Voting Rights
PremiumCompany Announcements
Ondine Biomedical Updates Director Shareholdings Amid Growth
PremiumCompany Announcements
Ondine Biomedical Secures Funding for Growth and Trials
PremiumCompany Announcements
Ondine Biomedical Increases Fundraising EffortsPremiumCompany Announcements
Ondine Biomedical Secures C$16.2 Million for US Trials
PremiumCompany Announcements
Ondine Biomedical Inc. Launches £8.5 Million Fundraise
PremiumCompany Announcements
Ondine Biomedical Inc. Secures Interim Funding BoostOptions Prices
Currently, No data available
---
Ownership Overview
OBI FAQ
What was Ondine Biomedical, Inc.’s price range in the past 12 months?
Ondine Biomedical, Inc. lowest share price was 5.00p and its highest was 11.40p in the past 12 months.
What is Ondine Biomedical, Inc.’s market cap?
Currently, no data Available
When is Ondine Biomedical, Inc.’s upcoming earnings report date?
Ondine Biomedical, Inc.’s upcoming earnings report date is May 15, 2025 which is in 169 days.
How were Ondine Biomedical, Inc.’s earnings last quarter?
Ondine Biomedical, Inc. released its earnings results on Sep 30, 2024. The company reported -0.019p earnings per share for the quarter, missing the consensus estimate of N/A by -0.019p.
Is Ondine Biomedical, Inc. overvalued?
According to Wall Street analysts Ondine Biomedical, Inc.’s price is currently Undervalued.
Does Ondine Biomedical, Inc. pay dividends?
Ondine Biomedical, Inc. does not currently pay dividends.
What is Ondine Biomedical, Inc.’s EPS estimate?
Ondine Biomedical, Inc.’s EPS estimate for its next earnings report is not yet available.
How many shares outstanding does Ondine Biomedical, Inc. have?
Ondine Biomedical, Inc. has 277,285,770 shares outstanding.
What happened to Ondine Biomedical, Inc.’s price movement after its last earnings report?
Ondine Biomedical, Inc. reported an EPS of -0.019p in its last earnings report, missing expectations of N/A. Following the earnings report the stock price went same 0%.
Which hedge fund is a major shareholder of Ondine Biomedical, Inc.?
Currently, no hedge funds are holding shares in GB:OBI
---
Ondine Biomedical, Inc. Stock Smart Score
Unlock Smart Score
1
2
3
4
5
6
7
8
9
10
Analyst Consensus
Moderate Buy
Average Price Target:
55.00p (566.67% Upside)
55.00p (566.67% Upside)
Insider Transactions
Bought Shares
Worth £1.1M over
the Last 3 Months
the Last 3 Months
Technicals
SMA
Positive
20 days / 200 days
Momentum
-13.15%
12-Months-Change
Fundamentals
Return on Equity
-675.80%
Trailing 12-Months
Asset Growth
-47.14%
Trailing 12-Months
Company Description
Ondine Biomedical, Inc.
Ondine Biomedical Inc is a life sciences company, focusing on the development of photodisinfection-based therapies to provide solutions to drug-resistant infections. The company has created a platform technology called antimicrobial photodynamic disinfection, or photodisinfection, to help prevent and help treat infections across different therapeutic areas in healthcare and industry settings.
---
OBI Stock 12 Month Forecast
Average Price Target
55.00p
▲(566.67% Upside)
Technical Analysis
Best Analysts Covering OBI
1 Year
1 Year Success Rate
3/5 ratings generated profit
1 Year Average Return
-3.54%
reiterated a buy rating 15 days ago
Copying Jack Reynolds-Clark's trades and holding each position for 1 Year would result in 60.00% of your transactions generating a profit, with an average return of -3.54% per trade.
---